Celdara Medical, Virtici, and MBV Announce Collaboration

 A collaborative network of affiliates to improve human health by developing the highest potential innovations.

“We’ve been working alongside the top innovators and their institutions for the better part of a decade, and the model clearly works.” said Jake Reder, Ph.D., cofounder and CEO of Celdara Medical. “We want to multiply our impact on human health, and today’s announcement of our partnership with MBV is both a nice parallel to our successful collaboration with Virtici, LLC, and the next step toward that goal. I want to make this very clear - if we were solely focused on maximizing profit we would compete against rather than cooperate with each other, but we’re all here for a greater purpose. Our primary purpose is to improve human health, so when any of us wins, we all win. Job creation, economic development, and windfall profits are wonderful things, and are byproducts of successful drugs, and this continuing model of geographic expansion reflects that vision.”

“The establishment of this collaborative network is exciting and provides a unique and dynamic environment,” said Neil Fanger, Ph.D., President and Chief Executive Officer of Virtici. “MBV leadership possess a significant amount of experience and a strong track record of innovative drug development. Our alignment strengthens our intelligence, knowhow and geographic reach, all of which will lead to the development of more exciting therapies and improved human health.   

“Even in the beginning stages of work with Celdara and Virtici, it was clear that their values aligned 100% with MBV’s, stated Joseph Trebley, Ph.D., Chief Executive Officer of MBV. There is rarely a conversation where patient need or human health doesn’t come up. Once we realized our values were aligned, it was a no-brainer to collaborate and form this trans-national partnership.”

The firms share best practices, dealflow, and a highly efficient business model for driving medical innovations from bench to boardroom to bedside. The collaborative model also extends to partnerships and even exits through the shared externalization of search, evaluation, derisking, and preclinical development functions for biotech and pharma companies. The firms are actively seeking innovators and diagnostic and therapeutic innovations with the potential to dramatically improve human health. While regionally concentrated, each company is also highly active beyond the geographies listed, with numerous partnerships across the country and beyond. 

About Celdara Medical, LLC 

Celdara Medical was founded by Drs. Jake Reder and Michael Fanger in 2008. CM has two locations, at the Dartmouth Regional Technology Center (DRTC) in Lebanon, NH, and in New York, NY. Celdara Medical builds academic and early-stage innovations into high-potential medical companies, identifying discoveries of exceptional value at the earliest stages and moving them toward the market. Celdara Medical partners with inventors and their institutions, providing the developmental, financial, and business acumen required to bridge discovery and profitability. With robust funding options, a diverse and high impact Programmatic pipeline, and partnerships with world-class academic institutions and industry leaders, Celdara Medical navigates all aspects of a complex industry, accelerating science to improve human health.

For more information about Celdara Medical, see celdaramedical.com or write to info@celdaramedical.com.

About Virtici, LLC 

Founded in 2011, Virtici is a privately held product-development company headquartered in Seattle, Washington. Virtici’s mission is to improve quality of life and save lives, and is primarily developing products to improve the way we diagnose and treat cancer, autoimmunity, and cardiovascular/metabolic diseases. Virtici, working closely with our affiliate Celdara Medical, partners with inventors and their research institutions, bringing the business and finance expertise to accelerate product development. Working with its partners in the pharmaceutical industry, Virtici connects the entire product development lifecycle by improving innovation, enhancing discovery and increasing product development efficiencies. 

For more information about Virtici, please visit www.virtici.com.

About MBV, LLC 

MBV, LLC was founded in 2015 to help inventors leverage their discoveries to improve human health. MBV partners with scientists to develop their ideas commercially by providing expertise in pre-clinical/clinical development, financing, intellectual property, licensing, and business development. MBV leverages a variety of funding sources and both internal and external expertise to develop products and partnerships in the biotechnology, medical device and pharmaceutical industries. Located in Indianapolis, IN, MBV has partnered with Celdara Medical and Virtici, providing decades of development experience on both coasts while working to develop the best from a large pool of under-accessed assets in the Midwest.

For more information about MBV, please visit www.mononbioventures.com